drugset / Trial / NCT06018883

Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer

NCT06018883

Phase 3 Active not recruiting 100 enrolled Fudan University
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of low-dose vitamin C on improving the quality of life for metastatic pancreatic cancer patients receiving gemcitabine and nab-paclitaxel chemotherapy.

Timeline

Start
2023-08-20
Primary completion
2025-08-15
Completion
2026-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C Other / unclassified 900 mg Oral
Background Gemcitabine Small molecule 1000 mg/m2
Background Paclitaxel Small molecule 120 mg/m2